Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades
Related
IAC Uses Reverse-IPO Maneuver With HomeAdvisor To Create $4.2-Billion Combo With Angie's List
4 Other Industries Augmented Reality Could Disrupt
Related CONE
Zacks Podcast Highlights: Looking For Top REIT Investments? Start Here For Your Guide
Benzinga's Top Upgrades, Downgrades For June 30, 2017

Analysts at Goldman Sachs upgraded Trulia (NYSE: TRLA) from “neutral” to “buy.” The target price for Trulia has been raised from $33 to $38. Trulia's stock closed at $29.47 on Friday.

Morgan Stanley upgraded CyrusOne (NASDAQ: CONE) from “equal-weight” to “overweight.” The target price for CyrusOne Stores is set to $25. CyrusOne's shares closed at $21.90 on Friday.

Analysts at BMO Capital upgraded Kansas City Southern (NYSE: KSU) from “underperform” to “market perform.” The target price for Kansas City Southern has been raised from $93 to $107. Kansas City Southern's shares closed at $111.37 on Friday.

Deutsche Bank upgraded GlaxoSmithKline PLC (NYSE: GSK) from “hold” to “buy.” GlaxoSmithKline's shares closed at $52.97 on Friday.

Latest Ratings for TRLA

DateFirmActionFromTo
Sep 2017Canaccord GenuityMaintainsBuy
Oct 2014Deutsche BankMaintainsHold
Jul 2014NeedhamDowngradesBuyHold

View More Analyst Ratings for TRLA
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (GSK + CONE)

View Comments and Join the Discussion!

Partner Center